68 /100
HIGH RISK
Score updated May 30, 2026

SXTP — 60 Degrees Pharmaceuticals, Inc. Dilution Risk Tracker

Track SXTP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SXTP — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
53%
🔁 Convertible Conversion 60%
• Major convertible overhang: 37% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration 50%
• Score rose 48 points recently (worsening)
• Score in HIGH risk zone (68/100)
🔄 Reverse Split 40%
• 50-day avg $1.65 approaching $1 threshold
• 7 months cash with weak price
🔔 Track SXTP — Get forecast alerts →

💹 Market Data

Market Cap$3.96M
Shares Outstanding2.66M
Float2.44M
Cash$3.34M
Debt$152.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 4.0% shares (2025Q4 vs prior)
7 institutional holders · 44.4K shares
#1 JANE STREET GROUP, LLC 22.1K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 12.4K shares
#3 Tower Research Capital LLC (TRC) 6.7K shares
+ 4 more holders Sign up free to view →

📉 Short Interest

Short Interest141.5K
Days to Cover2.5
% of Float5.8%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
424B5 ATM Mar 13, 2026
424B5 ATM Mar 11, 2026
424B5 ATM Mar 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track SXTP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SXTP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for SXTP
📊 SXTP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SXTP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.